{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on Postoperative Sore Throat Prevention"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "This randomised controlled trial was conducted in a hospital setting."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were adults undergoing elective surgery requiring tracheal intubation."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to receive either pharmacological interventions (NSAIDs or steroids), non-pharmacological interventions, or traditional Chinese medicine (TCM) therapy."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aims to evaluate the effectiveness of various interventions in preventing POST."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of POST within 24 hours post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised: 100 to the intervention group and 100 to the control group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "The analysis included 98 participants in the intervention group and 97 in the control group, using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant reduction in POST incidence compared to the control group (mean difference = 15%, 95% CI 10% to 20%; p < 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the intervention group and 1% in the control group experiencing minor side effects."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT12345678."
      },
      "Funding": {
        "score": 1,
        "evidence": "Funding: Supported by hospital intramural sources."
      }
    },
    "total_score": 22,
    "max_score": 25
  },
  "model": "gpt-4o"
}